Honz Pharmaceutical Co., Ltd.

SZSE:300086 Stock Report

Market Cap: CN¥2.3b

Honz Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jiangtao Hong

Chief executive officer

CN¥411.9k

Total compensation

CEO salary percentagen/a
CEO tenure5yrs
CEO ownership0.5%
Management average tenure5yrs
Board average tenure2yrs

Recent management updates

Recent updates

Honz Pharmaceutical Co., Ltd.'s (SZSE:300086) 32% Price Boost Is Out Of Tune With Revenues

Dec 02
Honz Pharmaceutical Co., Ltd.'s (SZSE:300086) 32% Price Boost Is Out Of Tune With Revenues

Honz Pharmaceutical Co., Ltd.'s (SZSE:300086) Shares Climb 31% But Its Business Is Yet to Catch Up

Sep 30
Honz Pharmaceutical Co., Ltd.'s (SZSE:300086) Shares Climb 31% But Its Business Is Yet to Catch Up

CEO

Jiangtao Hong (54 yo)

5yrs

Tenure

CN¥411,900

Compensation

Mr. Jiangtao Hong has been President at Honz Pharmaceutical Co., Ltd. since December 19, 2019 and served as its Vice President.


Leadership Team

NamePositionTenureCompensationOwnership
Jiangyou Hong
Chairman & Financial Director17yrsCN¥542.00k1.69%
CN¥ 39.5m
Jiangtao Hong
President5yrsCN¥411.90k0.51%
CN¥ 11.9m
Liping Hong
Vice Chairman & VP17yrsCN¥425.70k0.17%
CN¥ 3.9m
Dexin Lin
VP & Board Secretary12.9yrsCN¥374.50kno data
Yong Wang
Assistant to the Chairmanno dataCN¥324.00kno data
Yong Zhou
Accounting Supervisorno datano datano data

5.0yrs

Average Tenure

54yo

Average Age

Experienced Management: 300086's management team is seasoned and experienced (5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jiangyou Hong
Chairman & Financial Director17yrsCN¥542.00k1.69%
CN¥ 39.5m
Liping Hong
Vice Chairman & VP17yrsCN¥425.70k0.17%
CN¥ 3.9m
Qinghe Wu
Independent Director2yrsCN¥90.00kno data
Huan Xue Zheng
Independent Director2yrsCN¥90.00kno data
Youquan Li
Non-Independent Director5yrsCN¥180.00kno data
Dongxiong Hong
Director2yrsCN¥138.90kno data
Chunying Wang
Non-Employee Supervisor5yrsno data0.00011%
CN¥ 2.6k
Jicheng Zhang
Independent Director5yrsCN¥90.00kno data
Mengke Sun
Non-Employee Supervisor2yrsno datano data
Zhihui Hong
Non-Independent Directorless than a yearno datano data
Canhui Fang
Independent Directorless than a yearno datano data

2.0yrs

Average Tenure

55yo

Average Age

Experienced Board: 300086's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:40
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Honz Pharmaceutical Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guoxian JuFirst Capital Securities Co. LTD.
Zhouyu DengGuosen Securities Co., Ltd.
Quanbing LiWanlian Securities Co., Ltd.